The Pan-Cancer Screen: Still Early for Prime Time
Xconomy
JULY 18, 2016
I would be ecstatic to have a simple tool for my patients that could detect cancers like ovarian and pancreatic that currently have no effective screening approach. The most popular approach is screening blood for circulating tumor DNA (ctDNA), which several companies claim to reliably detect at very low levels in the blood.
Let's personalize your content